Use and safety of aprotinin in routine clinical practice: A European postauthorisation safety study conducted in patients undergoing cardiac surgery

BACKGROUND: Aprotinin has been used to reduce blood loss and blood product transfusions in patients at high risk of major blood loss during cardiac surgery. Approval by the European Medicines Agency (EMA) for its current indication is limited to patients at high risk of major blood loss undergoing i...

Descripción completa

Detalles Bibliográficos
Autores principales: De Hert, Stefan, Ouattara, Alexandre, Royston, David, van der Linden, Jan, Zacharowski, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Cardiac Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451913/
https://www.ncbi.nlm.nih.gov/pubmed/35766393
http://dx.doi.org/10.1097/EJA.0000000000001710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451913/
https://www.ncbi.nlm.nih.gov/pubmed/35766393
http://dx.doi.org/10.1097/EJA.0000000000001710

Ejemplares similares